Tuesday, 8 September 2026

When the Company Thinks: Sanofi India and the New Architecture of Corporate Criminal Liability

 


Introduction

A corporation has no hands with which to act and no mind with which to intend. Yet modern criminal law increasingly treats the corporation as a real institutional actor capable of causing public harm. The Supreme Court’s decision in Sanofi India Ltd. v. Central Bureau of Investigation, Criminal Appeal No. 4250 of 2026, reported as 2026 INSC 957, addresses the difficult bridge between corporate personality and criminal responsibility: when may the conduct and mens rea of a natural person be treated as the conduct and mens rea of the company?

Read full judgment here: Click here.

The Court held that a company may face prosecution for an offence requiring mens rea even when the individual employee, director or officer through whom the alleged offence was committed has neither been identified nor arraigned as a co-accused. However, the decision does not create automatic corporate liability. It rejects a formalistic threshold objection while insisting that the allegations must, at least prima facie, reveal corporate participation, a connection with the alleged offence, and circumstances making corporate mens rea legally possible.

The judgment is significant because it does more than answer whether a company may be prosecuted alone. It supplies, for the first time in a comprehensive manner, an Indian framework for attribution of a natural person’s act and state of mind to a corporation. That framework is hierarchical, transaction-specific and statute-sensitive. It combines constitutional authority, delegated authority and the purpose of the penal provision into a three-stage inquiry.

The case in context

Sanofi India Ltd., a pharmaceutical company, supplied medicines to the Rare Materials Project of the Bhabha Atomic Research Centre during different years. The CBI alleged that Dr. P. Anand, a BARC scientific officer, manipulated procurement processes by treating certain medicines as proprietary, excluding competing bidders or declining to place orders with the lowest bidder. The alleged conduct caused wrongful loss to BARC of approximately INR 3,53,361 and corresponding wrongful gain to the accused.

The prosecution further alleged that Dr. Anand received illegal gratification of INR 42,750 from Sanofi and that Sanofi abetted the commission of the relevant offence under the Prevention of Corruption Act, 1988. The charge-sheet arrayed Dr. Anand and Sanofi, but did not arraign any employee or officer of Sanofi.

Sanofi sought quashing of the proceedings under Section 482 of the Code of Criminal Procedure. Its central submission was that a company could not itself enter into a conspiracy or possess the requisite guilty mind unless the natural person constituting its alter ego or directing mind had first been identified and prosecuted. The Karnataka High Court rejected the challenge, holding that the allegations required examination at trial. The Supreme Court dismissed Sanofi’s appeal.

Issues before the Court

The immediate issue was whether criminal proceedings against a company should be quashed solely because no natural person had been identified and arraigned alongside it.

The Court necessarily examined connected and foundational questions:

·      Whether a corporation can be prosecuted for an offence requiring mens rea.

·      How the mental state of a natural person may be attributed to a corporation.

·      Whether the expression “directing mind and will” should be treated as a fixed legal test.

·      Whether identification of the individual source of corporate mens rea is necessary at the stage of quashing.

·      Whether arraignment of that individual is a condition precedent to prosecution of the company.

·      What minimum allegations must exist before a corporate prosecution can survive scrutiny under Section 482 CrPC.

The Court distinguished between the existence of corporate mens rea and the method by which mens rea is attributed. Earlier decisions, particularly Iridium India Telecom Ltd. v. Motorola Inc., had established that a corporation is not immune from prosecution merely because the offence requires mens rea. The attribution question—whose act and mental state count as those of the corporation—had not, however, received a comprehensive formulation from the Supreme Court.

The conceptual problem

Criminal responsibility traditionally rests on two elements: actus reus, the prohibited act, and mens rea, the guilty state of mind. The difficulty is that a company is an artificial legal person. It is separate from its members, but it can act only through human beings. If corporate personality is treated as a complete fiction, the company can neither act nor intend. If it is treated as an institutional reality, the law must determine when a human act becomes the company’s act rather than merely the act of an employee.

The Court identified this process as attribution. Attribution is not ordinary vicarious liability. It is the legal process by which the act and mental state of a natural person are treated as the act and mental state of the corporation itself. The distinction matters: in vicarious liability, the employee remains a separate actor whose conduct is imputed to the principal; in direct corporate liability through attribution, the law treats the relevant act as the corporation’s own act.

This distinction preserves the moral structure of criminal law. The company is not punished merely because an employee happened to commit an offence during employment. The prosecution must establish the legally relevant connection between the person, the transaction, the corporate authority and the statutory offence.

The jurisprudential journey

The Court traced the development of corporate criminal liability through English authorities because Indian law had affirmed the capacity of corporations to possess mens rea without sufficiently explaining how that mens rea is to be attributed.

In Lennard’s Carrying Co. v. Asiatic Petroleum Co., the House of Lords described the person who embodied the company’s “directing mind and will”. The importance of the decision lies in its recognition that the act of an appropriate corporate organ may be the very act of the company, rather than merely the act of an agent for which the company is answerable on the principle of respondeat superior.

In Tesco Supermarkets Ltd. v. Nattrass, the identification doctrine was developed more explicitly. It recognised that the board, managing director or another superior officer may speak and act as the company. It also accepted that a delegate may become the company’s embodiment when the board has conferred full discretion to act independently. Mere managerial discretion under continuing supervision, however, does not suffice.

The doctrine’s weakness was its tendency to encourage a search for a single corporate “brain”. Meridian Global Funds Management Asia Ltd. v. Securities Commission shifted the emphasis from corporate metaphysics to rules of attribution. The question is not who generally controls the company, but whose act or knowledge, for the purpose of the particular legal rule, should count as the company’s act or knowledge.

The Court also examined the Barclays cases, which supplied a sequential structure: first, examine the company’s constitutional allocation of power; next, examine express or implied delegation; and only thereafter consider whether the purpose of the statute requires a special rule of attribution. The Supreme Court adopted this structured approach for Indian law, while adapting it to the constitutional and statutory setting.

The three-stage attribution framework

The central doctrinal contribution of Sanofi India is the following hierarchical framework.

Stage one: constitutional authority

The first inquiry is whether the company’s constitutional documents, or a rule implied by company law, vest the relevant authority in the person whose conduct is sought to be attributed. The inquiry is transaction-specific: it asks who had the legal power to do the act in question, not who generally occupied the highest position in the company.

If the articles, governing instruments or company-law principles treat the act of a particular person as the act of the corporation, that person’s state of mind in performing the act may also be attributed to the corporation. The framework therefore begins with institutional design and legally vested authority, not with titles alone.

Stage two: delegated authority

If the answer is not supplied by the constitutional structure, the court examines whether authority was expressly or impliedly delegated to the concerned person. The delegation must carry sufficient discretion and independence in relation to the particular act or transaction.

The mere fact that a person negotiated, participated in discussions, signed a document or occupied a managerial position does not automatically establish attribution. A subordinate who acts within a chain of command remains an agent or servant unless the corporation has vested that person with authority to act independently in the relevant sphere. The inquiry is whether the person had authority to “do the deal”, not merely authority to contribute to the deal.

Stage three: statutory-purpose attribution

Where neither constitutional authority nor delegated authority provides an answer, the court considers whether the purpose of the statute requires a special rule of attribution. This is an exercise in statutory interpretation, not an unrestricted power to enlarge criminal liability.

For a narrowly framed statutory provision, the court may ask in the abstract whose act or state of mind the legislature intended to count as the corporation’s. For a broad offence capable of operating across varied factual situations, the inquiry must be linked to the facts and circumstances of the particular case. The court must ask whether refusing attribution in those circumstances would defeat the purpose of the statutory provision.

The third stage is therefore neither a presumption of guilt nor a licence to disregard corporate structures. It is a controlled means of ensuring that a company does not obtain the benefit of a statutory scheme while avoiding its corresponding responsibility merely because the relevant corporate decision was not formally recorded at board level.

Important safeguards

The framework is not a status-based rule. Being a director, managing director, chief executive or senior officer does not, by itself, make every act of that person the act of the company. The controlling question is the authority attached to the particular transaction, subject to the possibility that status may be relevant at the third stage when the statutory purpose is examined.

The inquiry is also transaction-specific. The same person may be the corporation’s embodiment for one matter but not for another. This prevents the law from attributing every act of a senior officer to the company merely because that officer generally occupies a position of influence.

The framework does not apply mechanically to every corporate offence. It is principally relevant where the offence is framed with natural persons in mind and requires proof of mens rea. It is unnecessary where the statute itself supplies the attribution rule, creates vicarious liability, directly imposes a duty on the corporation, or creates a strict or absolute liability offence.

Finally, attribution operates in one direction—from the natural person to the corporation. It does not determine the criminal liability of the natural person. The individual’s liability continues to be decided under ordinary criminal-law principles, independently of whether the person’s conduct is attributed to the company.

Non-identification and non-arraignment

The Court rejected the argument that the individual source of corporate mens rea must be identified before the company can be prosecuted. At the Section 482 stage, the charge-sheet must disclose that the corporation itself appears to have committed the offence; it need not identify the precise human being through whom every corporate act was performed.

The Court reasoned that identification goes principally to the strength and ultimate proof of the prosecution case. Attribution is often fact-intensive and may require examination of corporate documents, delegations, internal communications, transaction records and witness testimony. Those matters ordinarily belong to the trial rather than to a threshold quashing inquiry.

The same reasoning applies to arraignment. Since the framework fixes the corporation with direct liability once the conditions of attribution are satisfied, arraignment of a natural person is not a universal condition precedent to prosecution of the company. The Court expressly confined its holding to the question whether non-identification or non-arraignment, by itself, justifies quashing under Section 482 CrPC. It did not decide, in the abstract, whether identification or arraignment may be necessary at some other stage or under a different statutory regime.

The threshold test under Section 482

The judgment does not eliminate judicial scrutiny. The ordinary rule remains that proceedings may be quashed where the allegations do not disclose an offence or are merely bald and unsupported. The fact that the accused is a corporation does not give the prosecution immunity from scrutiny.

At the threshold, the allegations must at least prima facie disclose three matters:

1.      Human agency: some natural person or persons acted on behalf of the corporation.

2.     Offence connection: the conduct is referable to the offence alleged.

3.     Plausible mens rea: the surrounding circumstances do not make the existence of the requisite guilty mind patently absurd or inherently improbable.

The inquiry is broad and non-microscopic. It is not the stage for conclusively deciding whether the individual was the directing mind, whether a delegation was valid, or whether the corporate mental state has been proved beyond reasonable doubt. In Sanofi India, the allegations of preferential procurement, the alleged financial benefit and the alleged gratification supplied sufficient prima facie material to permit the prosecution to continue.

Jurisprudential significance

The decision represents a movement from anthropomorphic corporate theory to institutional attribution theory. The older language of a corporate “brain”, “ego” or “directing mind” can be useful as shorthand, but it can mislead if treated as a search for a permanent human substitute for the corporation. The Court instead asks a functional legal question: under the relevant rule and in relation to the relevant transaction, whose act and state of mind should count as the corporation’s?

This approach respects both sides of the criminal-law principle of legality. On one side, it prevents the corporate form from becoming a shield against responsibility for institutional wrongdoing. On the other, it prevents courts from imposing liability merely because an employee was connected with the company or because a senior officer held a formal title. Authority, statutory purpose and factual context must mediate between organisational reality and individual culpability.

The judgment also reflects a shift from an exclusively individualistic model of mens rea to a legally constructed institutional model. The corporation’s guilt is not a mystical mental state floating independently of human conduct. Nor is it automatically the aggregate of every employee’s knowledge. It is the result of a legally controlled attribution process that selects the relevant human act and mental state for the purpose of the offence in question.

The decision further illustrates the relationship between adjudication and legislation. The Court acknowledged that a broader system of corporate criminal liability—such as senior-management liability or failure-to-prevent offences—may be desirable, but stated that comprehensive expansion of liability is primarily a legislative task. Judicial interpretation can apply existing statutory purpose; it cannot freely redesign the penal code.

What is novel in the judgment?

The judgment’s novel contribution is not the proposition that companies can be prosecuted for offences requiring mens rea. That proposition had already been recognised in Iridium India. The real innovation lies in converting a previously unsettled question of attribution into a structured Indian doctrine.

The judgment introduces, or more precisely crystallises, five new doctrinal propositions for Indian corporate criminal law:

·      A three-stage hierarchy: corporate constitutional authority, delegated authority, and statutory-purpose attribution.

·      Transaction-specific attribution: the court need not identify a permanent or universal “directing mind” of the company.

·      No automatic status rule: office, designation or seniority alone does not establish attribution.

·      Threshold separation: identification and arraignment are not universal preconditions for prosecuting the company under Section 482 CrPC.

·      Prima facie corporate mens rea: surrounding conduct may disclose the possibility of corporate mens rea even before the individual source of that mens rea is conclusively identified.

The most important conceptual innovation is the separation of prosecution-stage sufficiency from trial-stage attribution. At the threshold, the prosecution need not prove the complete attribution chain. It must show enough corporate conduct and surrounding circumstances to make the alleged offence legally intelligible and prima facie plausible. At trial, the prosecution must establish the authority, delegation, transaction-specific connection and mental state necessary to fix direct criminal liability upon the company.

Guidance for trial courts

The judgment has practical consequences for the framing of charges, appreciation of evidence and adjudication of corporate prosecutions.

A trial court may consider the following sequence:

·      Identify the exact statutory offence and determine whether it creates direct, vicarious, strict or mens rea-based liability.

·      Examine whether the statute itself specifies the persons whose conduct is to be attributed to the corporation.

·      If no statutory rule applies, identify the particular transaction or omission in issue.

·      Examine the company’s articles, governing documents and applicable company-law principles.

·      Examine express or implied delegation, including the extent of discretion and independence actually conferred.

·      If the first two stages fail, consider the statutory purpose and whether a special rule of attribution is necessary on the facts.

·      Keep the company’s liability analytically separate from the individual’s liability.

·      Avoid treating designation alone as proof of corporate mens rea.

·      At the quashing stage, ask whether the allegations disclose the three minimum elements identified in paragraph 196 of the judgment; do not conduct a mini-trial.

The judgment also places a responsibility on investigating agencies. A charge-sheet against a company should not rely on the bare assertion that “the company” acted dishonestly. It should identify the relevant transaction, the persons who acted on the company’s behalf even if their formal names or roles remain uncertain, the corporate benefit or connection, the documentary trail, and the circumstances from which the alleged mental state may reasonably be inferred.

Critical evaluation

The judgment is balanced but not free from difficulty. Its first two stages promote certainty, yet they may be narrow in large corporations where decision-making is dispersed across committees, regional offices and layered management. Its third stage supplies flexibility, but the more broadly “statutory purpose” is framed, the greater the risk of inconsistent attribution and uncertainty in criminal law.

The Court appropriately declined to create a general status-based rule. A contrary rule could make a company liable for every wrongful act of a senior officer, even where the officer acted outside the relevant authority or against the company’s interests. At the same time, the judgment recognises that corporate wrongdoing may be deliberately distributed across several actors, making it difficult to identify one person possessing the complete mens rea. The decision leaves that difficult problem for future cases and possible legislative reform.

The distinction between non-identification and absence of human agency is particularly important. The prosecution need not name the person at the outset, but it must still show that some human conduct on behalf of the corporation is alleged and that the conduct is connected with the offence. Thus, the judgment prevents both extremes: corporations cannot defeat prosecution merely by pointing to an unidentified employee, and investigating agencies cannot prosecute a company through an empty formula unsupported by transaction-specific material.

Conclusion

Sanofi India Ltd. v. CBI marks a decisive development in Indian corporate criminal jurisprudence. It confirms that the corporate form is not a procedural shield, while equally insisting that corporate criminal liability must rest on principled attribution rather than automatic vicarious responsibility.

The judgment’s enduring formula may be stated thus: do not search for the company’s brain in the abstract; identify, in relation to the particular transaction and statutory offence, whose act and state of mind the law treats as the company’s own. At the Section 482 stage, the absence of a named or arraigned natural person is not fatal if the allegations disclose corporate participation, an offence-related human act and a plausible basis for mens rea. Whether the attribution is ultimately established remains a matter for trial.

For judges, the judgment provides a disciplined method of analysis. For investigators, it demands greater attention to corporate structure, delegation and documentary context. For companies, it signals that internal organisation cannot be used as a device to externalise the benefits of corporate conduct while insulating the corporation from criminal accountability.

Print Page

No comments:

Post a Comment